Hood River Capital Management LLC Beam Therapeutics Inc. Transaction History

Hood River Capital Management LLC

  • $5.4 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 14, 2023
BUY
$29.32 - $35.99 $411,242 - $504,795
14,026 Added 5.9%
251,633 $8.03 Million
Q1 2023

May 15, 2023
BUY
$30.15 - $48.79 $187,231 - $302,985
6,210 Added 2.68%
237,607 $7.28 Million
Q4 2022

Feb 14, 2023
BUY
$36.73 - $51.6 $52,083 - $73,168
1,418 Added 0.62%
231,397 $9.05 Million
Q3 2022

Nov 14, 2022
BUY
$39.79 - $70.31 $9.15 Million - $16.2 Million
229,979 New
229,979 $11 Million

Others Institutions Holding BEAM

# of Institutions
236
Shares Held
75.2M
Call Options Held
438K
Put Options Held
232K
View Full List

About Beam Therapeutics Inc.

BEAM Quotes by TradingView
  • Ticker BEAM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 70,354,600
  • Market Cap $2.04B
  • Description
  • Beam Therapeutics Inc., a biotechnology company, develops precision genetic medicines for patients suffering from serious diseases in the United States. The company is developing BEAM-101 for the treatment of sickle cell disease and beta thalassemia; BEAM-102 for the treatment of sickle cell disease; and BEAM-201, an allogeneic chimeric antigen ...
More about BEAM
Track This Portfolio

Track Hood River Capital Management LLC Portfolio

Follow Hood River Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hood River Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Hood River Capital Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email